Bond Screener
BioMarin Pharmaceutical
LEI NSLL8ITTRR0J5HEMR848
Organization name
BioMarin Pharmaceutical Inc.
Country name
USA
Country of registration
USA
Industry
Pharmaceutical Preparation and Biotechnology
Credit Ratings
in foreign currency
Public debt
1,450 mln USD
Upgrade to Premium features
Cbonds consolidates global bond, stock, ETF and indices data into a single platform — so you can analyze faster, make informed investment decisions and outperform the market
Get access
-
Full access to the largest bond database
Bond parameters,
prospectuses -
Seamless
Data exportAnalyze the data in the most efficient way
-
Bond pricing
Current & historical quotes from 400+ stock exchanges & OTC market
-
Smart risk assessment
Credit ratings, financial reports
Trading Schedule Issuer map
Quotes
/
/
/
pcs.
pcs.
pcs.
- «
- 1
- ...
- {{ quotes.page - 2 }}
- {{ quotes.page - 1 }}
- {{ quotes.page }}
- {{ quotes.page + 1 }}
- {{ quotes.page + 2 }}
- ...
- {{ quotesLastPage }}
- »
Quotes provided by information providers are indicative in nature
Profile
|
BioMarin develops and commercializes innovative biopharmaceuticals for serious diseases and medical conditions.
|
General information
-
Organization nameBioMarin Pharmaceutical Inc.
-
Organization statusOperating organization
-
Address105 Digital Drive Novato, USA, 94949
-
Site
News
IFRS/US GAAP reports
| 2025 | |
| 2024 | |
| 2023 | |
| 2022 | |
| 2021 | |
| 2020 | |
| 2019 | |
| 2018 | |
| 2017 | |
| 2016 | |
| 2015 | |
| 2014 | |
Show all
Hide
Authorization required
You need to request access
Stocks
General information
-
Organization nameBioMarin Pharmaceutical Inc.
-
Organization statusOperating organization
-
Address105 Digital Drive Novato, USA, 94949
-
Site
Codes
-
LEINSLL8ITTRR0J5HEMR848
-
SIC2834 PHARMACEUTICAL PREPARATIONS
-
NACE*** ***
-
NAICS*** ***
-
CIK0001048477
-
EIN68-0397820
